Dr. Meaghan Morris is a neuropathologist and neuroscientist whose research focuses on understanding the molecular basis for Alzheimer’s disease and other age-related dementias, with the ultimate goal of identifying new therapeutic targets for Alzheimer’s disease treatment. These investigations combine insights from brain tissue donated by patients with age-related neurodegenerative diseases, studies in cell culture models, and cutting edge molecular techniques to uncover new pathways involved in Alzheimer’s disease. Currently, her research is focused on how neuronal function and neuronal synapses are regulated by the microtubule-associated protein tau, a key pathologic protein which aggregates in Alzheimer’s disease and dementias.
